2021
DOI: 10.1016/j.jaip.2020.11.023
|View full text |Cite
|
Sign up to set email alerts
|

Hypersensitivity to gadolinium-based contrast agents: A single-center retrospective analysis over 7 years

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

2
25
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 13 publications
(28 citation statements)
references
References 9 publications
2
25
0
Order By: Relevance
“…8 As Jung et al previously indicated, 4 in our experience, gadobenate dimeglumine was the more frequent agent implicated in the hypersensitivity reactions. Differently, in a retrospective analysis of patients investigated by Mankouri et al 9 gadoteric acid was the most frequently GBCA reported by patients as the cause of a reaction, followed by gadobenic acid. Two of the three patients who had a reaction with a linear GBCA showed a cross-reactivity also for a macrocyclic agent having the same net charge.…”
Section: Discussionmentioning
confidence: 88%
See 3 more Smart Citations
“…8 As Jung et al previously indicated, 4 in our experience, gadobenate dimeglumine was the more frequent agent implicated in the hypersensitivity reactions. Differently, in a retrospective analysis of patients investigated by Mankouri et al 9 gadoteric acid was the most frequently GBCA reported by patients as the cause of a reaction, followed by gadobenic acid. Two of the three patients who had a reaction with a linear GBCA showed a cross-reactivity also for a macrocyclic agent having the same net charge.…”
Section: Discussionmentioning
confidence: 88%
“…Cross-reactivity in skin tests has recently been demonstrated in one third of allergic patients. 9 However, some previous reports showed no cross-reactivity between GBCAs 10 , 11 while others showed cross-reactivity between gadobutrol and gadoteridol 12 and between gadobutrol and several both linear and macrocyclic agents. 9 , 13 These findings cannot allow us to draw any conclusion on cross-reactivity and further studies are needed to clarify this mechanism.…”
Section: Discussionmentioning
confidence: 96%
See 2 more Smart Citations
“…Cross-reactivity among GBCAs has not been adequately addressed [1,2,3,6,7,8,12]. Kolenda et al [7] described 30 patients with immediate reactions to GBCAs, finding J Investig Allergol Clin Immunol 2021; Vol.…”
mentioning
confidence: 99%